chitosan has been researched along with tacrolimus in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 7 (46.67) | 2.80 |
| Authors | Studies |
|---|---|
| Boorsma, A; Brul, S; Hellingwerf, KJ; Klis, FM; Zakrzewska, A | 1 |
| Fu, CY; Lü, DC; Qü, W; Zhang, WG | 1 |
| Li, X; Ma, X; Wang, G; Wang, W; Wei, G; Zhang, W | 1 |
| Fu, C; Qu, W; Wei, G; Zhang, W; Zhao, J; Zheng, X | 1 |
| Choi, HG; Hwang, HS; Lee, C; Lee, EH; Lee, ES; Lee, S; Seo, J; Thao, LQ; Youn, YS | 1 |
| Al Bustami, RT; Awad, AA; Obaidat, RM; Tashtoush, BM | 1 |
| Cao, S; Ruan, W; Wan, T; Wang, Y; Wu, C; Xu, Y; Yu, K; Zhai, Y | 1 |
| Abnous, K; Alibolandi, M; Mansouri, A; Ramezani, M; Taghdisi, SM | 1 |
| Ahmad, Z; Bukhari, NI; Hussain, I; Hussain, SZ; Khan, MI; Sarwar, HS; Shahnaz, G; Siddique, MI; Sohail, MF | 1 |
| Bae, EH; Kim, CS; Kim, SW; Mathew, AP; Moon, MJ; Park, IK; Uthaman, S | 1 |
| Bae, EH; Joo, SY; Kim, CS; Kim, SW; Ma, SK; Mathew, AP; Park, IK; Uthaman, S; Vasukutty, A | 1 |
| Bhatia, M; Garg, V; Jain, GK; Kesharwani, P; Modi, D; Warsi, MH | 1 |
| Abdel-Mottaleb, MMA; Arafa, MG; El-Zaafarany, GM; Fereig, SA | 2 |
| Abdel-Mottaleb, MMA; Arafa, MG; El-Zaafarany, GM; Fereig, S | 1 |
15 other study(ies) available for chitosan and tacrolimus
| Article | Year |
|---|---|
Transcriptional response of Saccharomyces cerevisiae to the plasma membrane-perturbing compound chitosan.
Topics: Apoptosis; beta-Glucans; Calcineurin; Cell Membrane; Cell Proliferation; Cell Wall; Chitosan; DNA-Binding Proteins; Drug Resistance, Fungal; Gene Expression Profiling; Gene Expression Regulation, Fungal; Glucan 1,3-beta-Glucosidase; MADS Domain Proteins; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Deletion; Signal Transduction; Tacrolimus; Trans-Activators; Transcription Factors; Transcription, Genetic | 2005 |
[Favorable effect of chitosan sustained-release FK506 incorporated conduits on axonal regeneration in rat sciatic nerve].
Topics: Animals; Axons; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Immunosuppressive Agents; Male; Nerve Regeneration; Random Allocation; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Tacrolimus | 2006 |
Immunophilin FK506 loaded in chitosan guide promotes peripheral nerve regeneration.
Topics: Animals; Chitosan; Drug Delivery Systems; Immunophilins; Nerve Growth Factor; Nerve Regeneration; Rats; Recovery of Function; Sciatic Nerve; Tacrolimus | 2010 |
FK506-loaded chitosan conduit promotes the regeneration of injured sciatic nerves in the rat through the upregulation of brain-derived neurotrophic factor and TrkB.
Topics: Animals; Biocompatible Materials; Brain-Derived Neurotrophic Factor; Chitosan; Disease Models, Animal; Drug Combinations; Electric Stimulation; Evoked Potentials; GAP-43 Protein; Immunosuppressive Agents; Male; Nerve Regeneration; Neural Conduction; Rats; Rats, Wistar; Receptor, trkB; Sciatic Neuropathy; Tacrolimus; Time Factors; Up-Regulation | 2014 |
Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
Topics: Administration, Inhalation; Aerosols; Animals; Bleomycin; Chitosan; Collagen; Hydroxyproline; Imaging, Three-Dimensional; Lactic Acid; Lung; Male; Mice, Inbred C57BL; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pulmonary Fibrosis; Static Electricity; Surface Properties; Tacrolimus; X-Ray Diffraction | 2016 |
Using Supercritical Fluid Technology (SFT) in Preparation of Tacrolimus Solid Dispersions.
Topics: Biological Availability; Chitosan; Crystallization; Methylcellulose; Polyethylene Glycols; Polymers; Polyvinyls; Pyrrolidines; Solubility; Surface-Active Agents; Tacrolimus; Technology, Pharmaceutical; Temperature | 2017 |
Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose.
Topics: Administration, Cutaneous; Animals; Chitosan; Dermatitis, Atopic; Dinitrochlorobenzene; Drug Delivery Systems; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Niacinamide; Ointments; Rats, Sprague-Dawley; Skin; Skin Absorption; Tacrolimus; Treatment Outcome | 2018 |
Targeted delivery of tacrolimus to T cells by pH-responsive aptamer-chitosan- poly(lactic-co-glycolic acid) nanocomplex.
Topics: Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Hydrogen-Ion Concentration; Jurkat Cells; Nanoparticles; Particle Size; Polylactic Acid-Polyglycolic Acid Copolymer; T-Lymphocytes; Tacrolimus | 2019 |
Fabrication and Characterization of Thiolated Chitosan Microneedle Patch for Transdermal Delivery of Tacrolimus.
Topics: Animals; Chitosan; Diffusion Chambers, Culture; Disulfides; Drug Delivery Systems; Equipment Design; Immunosuppressive Agents; Microinjections; Needles; Rats; Skin; Sulfhydryl Compounds; Tacrolimus; Tensile Strength; Transdermal Patch | 2020 |
Glycol chitosan-based renal docking biopolymeric nanomicelles for site-specific delivery of the immunosuppressant.
Topics: Animals; Cell Line; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Humans; Hydrophobic and Hydrophilic Interactions; Immunosuppressive Agents; Kidney; Male; Mice, Inbred BALB C; Micelles; Nanoparticles; Tacrolimus | 2020 |
Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis.
Topics: Animals; Apoptosis; Chitosan; Female; Fibrosis; Gene Expression; Hydrophobic and Hydrophilic Interactions; Inflammation; Kidney; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Micelles; NF-kappa B; Signal Transduction; Tacrolimus | 2021 |
Formulation development, optimization, and in vitro assessment of thermoresponsive ophthalmic pluronic F127-chitosan
Topics: Chitosan; Drug Delivery Systems; Gels; Poloxamer; Tacrolimus | 2021 |
Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis.
Topics: Administration, Cutaneous; Animals; Chitosan; Drug Carriers; Drug Liberation; Ear; Imiquimod; Immunosuppressive Agents; Mice, Inbred C57BL; Nanoparticles; Particle Size; Psoriasis; Rats, Sprague-Dawley; Skin; Tacrolimus | 2021 |
Self-assembled tacrolimus-loaded lecithin-chitosan hybrid nanoparticles for in vivo management of psoriasis.
Topics: Animals; Chitosan; Drug Carriers; Lecithins; Mice; Nanoparticles; Particle Size; Psoriasis; Tacrolimus | 2021 |
Boosting the anti-inflammatory effect of self-assembled hybrid lecithin-chitosan nanoparticles via hybridization with gold nanoparticles for the treatment of psoriasis: elemental mapping and
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Gold; Lecithins; Metal Nanoparticles; Mice; Psoriasis; Tacrolimus | 2022 |